Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERTY 1: Relugolix in Uterine Fibroids
NCT03049735Phase 3Completed
- Sponsor
- Myovant Sciences
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 6
01
Overview
A Phase 3 trial of relugolix in Uterine Fibroids (UF), sponsored by Myovant Sciences. Started Apr 2017; status: completed.
02
Drugs
relugolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03049735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03049735.